* Gohealth Inc GOCO.OQ GOCO.O is expected to show a fall
in
quarterly revenue when it reports results on May 8.
* The Chicago Illinois-based company is expected to report
a
31.6% decrease in revenue to $184.981 million from $270.59
million a year ago, according to the mean estimate from 4
analysts, based on Refinitiv data.
* Refinitiv's mean analyst estimate for Gohealth Inc is for
a
loss of $1.96 per share.
* The current average analyst rating on the shares is "hold"
and
the breakdown of recommendations is 1 "strong buy" or "buy," 1
"hold" and 2 "sell" or "strong sell."
* The mean earnings estimate of analysts had risen by
about 17.2%
in the last three months.
* Wall Street's median 12-month price target for Gohealth
Inc is
$11, above its last closing price of $9.57.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM REFINITIV ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT IBES MET, SE %
E® ESTIMATE MISSED
Dec. 31 2022 1.49 1.33 -7.00 Missed -626.4
Sep. 30 2022 -4.24 -4.30 -3.30 Beat 23.3
Jun. 30 2022 -3.75 -3.38 -2.25 Beat 33.4
Mar. 31 2022 -1.29 -1.33 -1.80 Missed -35.3
Dec. -2.09 2.22 30.15 Beat 1,255.
31 2021 1
Sep. 30 2021 -1.42 -1.49 -2.70 Missed -80.9
Jun. 30 2021 -0.73 -0.66 -1.80 Missed -170.9
Mar. 31 2021 -0.16 -0.15 -0.30 Missed -106
This summary was machine generated May 5 at 18:34 GMT. All
figures in US dollars unless otherwise stated